Effects of an exercise intervention on exercise capacity in adults with
Cystic Fibrosis treated with and without
elexacaftor/tezacaftor/ivacaftor
Abstract
Background The effect of CFTR modulators on exercise capacity
in people with CF (pwCF) is controversial. In addition, the effect of
elexacaftor/tezacaftor/ivacaftor (ETI) on improving exercise capacity
after an exercise intervention is not known. We aimed to evaluate the
effects of an exercise intervention in adult pwCF in the presence or
absence of ETI treatment. Methods 56 adult pwCF participated in
an exercise intervention during a 4-week rehabilitation course. The
exercise program consisted of 5 sessions per week of 45 minutes each,
including 3 endurance sessions on a cycle ergometer. Peak oxygen uptake
(VO2peak) and peak workload (Wpeak) were used as primary outcomes to
assess changes in exercise capacity. Results The training
intervention led to a significant increase in VO2peak and Wpeak in all
pwCF with or without ETI. The degree of improvement did not differ
between the groups treated with and without ETI. PwCF with lower fitness
(VO2 ≤ 81%pred) benefited more than pwCF with higher fitness (VO2peak
≥82%pred). The degree of improvement in VO2peak and Wpeak in the
fitness groups with and without ETI was comparable and did not differ
significantly from each other. Conclusion The use of ETI has
little or no effect on the degree of improvement in VO2peak and Wpeak.
This suggests that other factors, such as level of exercise capacity and
physical inactivity, may determine the degree of improvement in exercise
capacity in adult pwCF. In general, adult pwCF with and without ETI
benefit from exercise interventions and can improve their exercise
capacity.